An approvable letter is sent by the FDA when a drugmaker's New Drug Application is not sufficient for approval, but has the potential to be approved at a later date. The letter spells out what problems the FDA had with the marketing application. Often times further meetings with the FDA are required to determine what needs to be done to get the drug approved.
Recent Mentions on Fool.com
- 3 Small-Cap Biotech Stocks That Could Be Top Stocks in 2015
- The Real Winner in a Staples-Office Depot Merger Isn't You
- Is Your Netflix Streaming About to Slow Down? Ask the FCC
- Family Dollar is Taxing Dollar Tree's Patience
- The Drug Development Process: 9 Steps From the Laboratory to Your Medicine Cabinet
- New Regulations Are a Boon to Shadow Banking